Join the search for an effective treatment therapy . . .A clinical study is enrolling now in West Palm Beach, FL
The purpose of the study is to evaluate the safety and effectiveness of an investigational oral drug compared to semaglutide in subjects with Type 2 Diabetes that is inadequately controlled with Metformin.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/dm2-on-metformin/
